Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 31 Carcinoma, Renal Cell 19 Carcinoma, Non-Small-Cell Lung 19 Neoplasm Metastasis 11 Carcinoma, Hepatocellular 9 Brain Neoplasms 8 Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Pancreatic Neoplasms 5 Lung Neoplasms 5 Clear-cell metastatic renal cell carcinoma 5 Carcinoma, Transitional Cell 5 Uveal Melanoma 4 Skin Neoplasms 4 Prostatic Neoplasms 4 Ovarian Neoplasms 4 Multiple Myeloma 4 Mesothelioma 4 Kidney Neoplasms 4 Glioblastoma 4 Carcinoma, Basal Cell 4 Carcinoma 4 Sarcoma 3 Recurrence 3 Myelodysplastic Syndromes 3 Liver Neoplasms 3 Leukemia, Myeloid, Acute 3 Gliosarcoma 3 Colorectal Neoplasms 3 Breast Neoplasms 3

Interventions

evolocumab 1 Nivolumab 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Lung Cancer Metastatic × Ipilimumab × 90 days × Clear all

NCT05144529 2026-05-05

TOP2101

Duke University

Phase 2 Terminated

19 enrolled 16 charts

Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡